AzurRx BioPharma, Inc. | Business Contracts

Description of Capital Stock (Filed With SEC on March 20, 2023)

Form of Settlement Agreement, by and between the Representative and the Company, dated November 30, 2022 (Filed With SEC on December 2, 2022)

Employment Agreement by and between First Wave BioPharma, Inc. and Sarah Romano, dated February 14, 2022 (Filed With SEC on February 17, 2022)

Agreement and Plan of Merger, dated September 13, 2021, by and among the Company, Alpha Merger Sub, Inc., First Wave Bio, Inc. and Fortis Advisors LLC, as shareholders... (Filed With SEC on September 13, 2021)

License Agreement, dated December 31, 2020, by and between the Company and First Wave Bio, Inc (Filed With SEC on January 13, 2021)

Selling Agent Agreement, by and between AzurRx BioPharma, Inc. and Alexander Capital, L.P., dated May 9, 2019 (Filed With SEC on May 14, 2019)

Form of Registration Rights Agreement (Filed With SEC on March 15, 2023)

Form of Purchase Agreement (Filed With SEC on March 15, 2023)

Form of Warrant (Filed With SEC on March 15, 2023)

Form of Pre-Funded Warrant (Filed With SEC on March 15, 2023)

Form of Registration Rights Agreement (Filed With SEC on November 22, 2022)

Form of Purchase Agreement (Filed With SEC on November 22, 2022)

Form of Warrant Amendment Agreement (Filed With SEC on November 22, 2022)

Form of Warrant (Filed With SEC on November 22, 2022)

Form of Pre-Funded Warrant (Filed With SEC on November 22, 2022)

Form of Warrant (Filed With SEC on October 12, 2022)

Form of Pre-Funded Warrant (Filed With SEC on October 12, 2022)

Form of Purchase Agreement (Filed With SEC on October 12, 2022)

Form of Securities Purchase Agreement (Filed With SEC on September 22, 2022)

Form of Placement Agent Warrant (Filed With SEC on September 22, 2022)

Form of Common Warrant (Filed With SEC on September 22, 2022)

Form of Pre-Funded Warrant (Filed With SEC on September 22, 2022)

Form of Term Sheet, by and between the Representative and the Company, dated July 29, 2022 (Filed With SEC on July 29, 2022)

Form of Registration Rights Agreement (Filed With SEC on July 18, 2022)

Form of Purchase Agreement (Filed With SEC on July 18, 2022)

Form of Placement Agent Warrant (Filed With SEC on July 18, 2022)

Form of Warrant (Filed With SEC on July 18, 2022)

Form of Waiver Agreement (Filed With SEC on May 13, 2022)

Form of Indemnification Agreement (Filed With SEC on May 5, 2022)

Description of Capital Stock (Filed With SEC on March 31, 2022)

Form of Warrant Amendment Agreement (Filed With SEC on March 1, 2022)

Form of Purchase Agreement (Filed With SEC on March 1, 2022)

Form of Placement Agent Warrant (Filed With SEC on March 1, 2022)

Form of Series C Warrant (Filed With SEC on March 1, 2022)

Form of Pre-Funded Warrant (Filed With SEC on March 1, 2022)

Form of Waiver (Filed With SEC on February 7, 2022)

Settlement Agreement, by and between the Company and Fortis Advisors LLC, dated November 15, 2021 (Filed With SEC on November 16, 2021)

Form of Wainwright Warrant (Filed With SEC on July 27, 2021)

Amended and Restated Underwriting Agreement, dated July 22, 2021, between AzurRx BioPharma, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on July 27, 2021)

Form of Wainwright Warrant (Filed With SEC on March 10, 2021)

Form of Warrant (Filed With SEC on March 10, 2021)

Form of Wainwright Warrant (Filed With SEC on January 8, 2021)

Employment Agreement by and between AzurRx BioPharma, Inc. and Mr. Schneiderman, dated January 1, 2020 (Filed With SEC on January 6, 2020)

Employment Agreement by and between AzurRx BioPharma, Inc. and James Sapirstein, dated October 8, 2019 (Filed With SEC on October 11, 2019)

Form of Wainwright Warrant (Filed With SEC on July 22, 2019)

Underwriting Agreement, dated July 17, 2019 (Filed With SEC on July 22, 2019)

Form of Selling Agent Warrant (Filed With SEC on May 14, 2019)

Selling Agent Agreement, by and between AzurRx BioPharma, Inc. and Alexander Capital, L.P., dated April 1, 2019 (Filed With SEC on April 3, 2019)

Form of Selling Agent Warrant (Filed With SEC on April 3, 2019)

Patent License Agreement, by and betweenAzurRxBioPharma, Inc. andLaboratoiresMayolySpindler SAS, dated March 27, 2019 (Filed With SEC on April 1, 2019)

AssetPurchaseAgreement, by and betweenAzurRxBioPharma, Inc.,AzurRxBioPharmaSAS andLaboratoiresMayolySpindler SAS, dated March 27, 2019 (Filed With SEC on April 1, 2019)

Form of Pledge Agreement, dated February 14, 2019 (Filed With SEC on February 20, 2019)

Senior Convertible Note B, dated February 14, 2019 (Filed With SEC on February 20, 2019)

Senior Convertible Note A, dated February 14, 2019 (Filed With SEC on February 20, 2019)

Warrant Amendment Agreement, dated February 14, 2019 (Filed With SEC on February 20, 2019)

Registration Rights Agreement, dated February 14, 2019 (Filed With SEC on February 20, 2019)

Note Purchase Agreement, dated February 14, 2019 (Filed With SEC on February 20, 2019)

AzurRx BioPharma, Inc. (57)